Real-time enrollment status for this relapsed acute myeloid leukemia clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 9:25 PM UTC
| NCT Number | NCT07320235 |
| Recruiting Status | Recruiting |
| Condition | Relapsed Acute Myeloid Leukemia |
| Phase | PHASE1 |
| Target Enrollment | 36 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Douglas Tremblay |
| Last Updated on CT.gov | April 22, 2026 (Apr 22, 2026) |
As of July 16, 2026: Clinical trial NCT07320235 is currently recruiting participants. This phase1 study for relapsed acute myeloid leukemia is actively seeking new participants at 1 location across the United States. The study is sponsored by Douglas Tremblay. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07320235 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07320235 was last updated Apr 22, 2026 (April 22, 2026). HelloStudys verifies this status automatically.